首页> 美国卫生研究院文献>Annals of Family Medicine >Glycemic Control in Medical Inpatients with Type 2 Diabetes Mellitus Receiving Sliding Scale Insulin Regimens versus Routine Diabetes Medications: A Multicenter Randomized Controlled Trial
【2h】

Glycemic Control in Medical Inpatients with Type 2 Diabetes Mellitus Receiving Sliding Scale Insulin Regimens versus Routine Diabetes Medications: A Multicenter Randomized Controlled Trial

机译:在接受滑动量表胰岛素治疗的2型糖尿病住院患者的血糖控制与常规糖尿病药物的比较:多中心随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>PURPOSE Hospitalized patients with type 2 diabetes mellitus traditionally receive insulin on a sliding-scale regimen, but the benefits of this approach are unclear. The purpose of this study was to compare the effects of the sliding scale insulin regimen with those of routine diabetes medications on hyperglycemia, hypoglycemia and length of hospitalization in diabetic patients hospitalized for other conditions.>METHODS This was a multicenter, randomized controlled trial conducted in family medicine inpatient services. One hundred fifty-three patients with type 2 diabetes mellitus hospitalized for other conditions were randomized to receive routine diabetes medications (control) or the combination of a standard sliding-scale insulin regimen and routine diabetes medications (intervention). The outcome measures included frequency of hyperglycemia and hypoglycemia (glycemic events), and length of hospitalization.>RESULTS No differences were identified between treatment groups in the frequency of glycemic events. In the intervention group, 33.3% of patients developed hyperglycemia compared to 34.6% in the control group (P = .87). Six patients developed hypoglycemia in the intervention group, compared with 7 in the control group (P = .83). There was no difference in length of hospitalization (P = .86). Regardless of treatment assignment, patients receiving intermediate-acting insulin (OR, 2.8; 95% CI, 1.2–6.5), those with blood glucose values greater than 250 mg/dL at baseline (OR, 6.3; 95% CI, 2.3 – 17.2) and those receiving corticosteroids (OR, 9.1; 95% CI, 3.1 – 27.0) were more likely to have glycemic events.>CONCLUSIONS The use of the sliding scale insulin regimen in combination with routine diabetes medications does not affect the rate of hyperglycemia, hypoglycemia or length of hospitalization in patients with type 2 diabetes mellitus hospitalized for other conditions.
机译:>目的传统上,住院的2型糖尿病患者采用滑动量表疗法接受胰岛素治疗,但是这种方法的益处尚不清楚。这项研究的目的是比较滑动刻度胰岛素治疗方案与常规糖尿病药物治疗对其他住院糖尿病患者的高血糖,低血糖和住院时间的影响。>方法 ,在家庭医学住院服务中进行的随机对照试验。 153例因其他情况住院的2型糖尿病患者被随机分配接受常规糖尿病药物(对照组)或标准滑尺胰岛素治疗与常规糖尿病药物的组合(干预)。结果指标包括高血糖和低血糖的发生频率(血糖事件)以及住院时间。>结果在各治疗组之间没有发现血糖事件发生频率的差异。在干预组中,33.3%的患者出现高血糖,而对照组为34.6%(P = .87)。干预组有6名患者发生了低血糖,而对照组只有7名(P = .83)。住院时间无差异(P = 0.86)。无论采用何种治疗方法,接受中效胰岛素治疗的患者(OR,2.8; 95%CI,1.2–6.5),基线时血糖值大于250 mg / dL的患者(OR,6.3; 95%CI,2.3 – 17.2) )和接受皮质类固醇激素治疗(OR,9.1; 95%CI,3.1 – 27.0)的人更容易发生血糖事件。>结论影响因其他情况而住院的2型糖尿病患者的高血糖,低血糖发生率或住院时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号